Semaine Peri/Meno Essentials Menopause Supplement - 60 Vegan Capsules
Semaine Peri/Meno Essentials Menopause Supplement - 60 Vegan Capsules
Product details
Semaine Peri/Meno Essentials is a menopause supplement designed to support women through all stages of the transition, from perimenopause through post-menopause. This formula combines Mediterranean polyphenols, including red clover extract standardized to deliver 50 mg of isoflavones, along with bergamot phytosome and olive extract to address the six systems affected when estrogen shifts.
Key Features
- Red clover extract standardized to 20%, delivering 50 mg total isoflavones (genistein, daidzein, biochanin A, formononetin)
- Bergamot phytosome and olive extract standardized for hydroxytyrosol
- Formulated for women ages 40 to 57 and suitable for all stages of menopause transition
- Vegan capsules, soy-free, gluten-free, hormone-free, Non-GMO
- Made in the USA with globally sourced ingredients, lot-tested for heavy metals and microbials
- Two capsules daily with breakfast; 30-day supply
How to Use
Take two capsules with breakfast daily.
Who Is It For
This supplement is designed for women aged 40 and older experiencing perimenopause, menopause or post-menopause symptoms. It supports women noticing early changes in their late 30s through those years past their last period.
Product Details
| Brand | Semaine |
|---|---|
| Form | Vegan Capsules |
| Size | 60 Capsules |
Frequently asked questions
How long does one bottle last?
One bottle contains 60 capsules, which is a 30-day supply when taking two capsules daily.
What are isoflavones and why are they included?
Isoflavones are phytoestrogens—plant compounds most studied for their interaction with estrogen receptor beta. This formula delivers 50 mg of total isoflavones from red clover extract.
Is this product suitable for vegans?
Yes, the capsules are vegan. The formula is also soy-free, gluten-free, hormone-free and Non-GMO.
What does the research show?
In a study of 42 women ages 40 to 57, 90% reported improvement in hot flashes and sweating by month three, and 86% reported improvement in sleep.